V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019824 | 270008487 | 0 | 121.4 | null | 2018-07-03 | 2018-09-06 | COPP + Dacarbazine | N | N | 270012909 | COPP + DACARBAZINE |
| 270019825 | 270008561 | 1.97 | 93.2 | Palliative (P) | 2016-06-08 | 2017-02-03 | CETUXIMAB | 2 | N | 270013228 | CETUXIMAB |
| 270019826 | 270008585 | 1.83 | null | Curative (C) | 2015-03-18 | 2015-03-18 | OEPA | N | Y | 270013366 | OEPA |
| 270019827 | 270008634 | 1.52 | 76.299 | Adjuvant (A) | 2016-10-22 | 2016-10-23 | OEPA | N | N | 270013582 | OEPA |
| 270019828 | 270008679 | 1.72 | 78.6 | null | 2017-12-22 | 2017-12-31 | CISPLATIN + RT | N | N | 270013969 | CISPLATIN + RT |
| 270019829 | 270018245 | 0.98 | 101.5 | Curative (C) | 2017-12-17 | 2017-12-24 | OEPA | 02 | N | 270013992 | OEPA |
| 270019830 | 270014111 | null | 153.2 | Disease modification (D) | 2015-04-22 | 2015-04-22 | LEAM | 02 | N | 270014097 | LEAM |
| 270019831 | 270008723 | 1.83 | 101.5 | Curative (C) | 2016-08-14 | 2016-08-14 | OEPA | 02 | null | 270014196 | OEPA |
| 270019832 | 270008729 | 1.8 | 68 | Curative (C) | null | 2016-05-12 | OEPA | N | N | 270014220 | OEPA |
| 270019833 | 270008744 | 1.8 | 58.9 | Adjuvant (A) | 2019-09-01 | 2019-09-01 | Rituximab (INTRAVENOUS Maintenance) | N | N | 270014274 | RITUXIMAB |
| 270019834 | 270014142 | 1.9 | 158 | Disease modification (D) | 2018-04-24 | 2018-04-24 | LEAM | null | null | 270014409 | LEAM |
| 270019835 | 270008795 | 1.75 | 54.7 | Curative (C) | 2018-12-05 | 2018-12-29 | BEAM | N | N | 270014445 | BEAM |
| 270019836 | 270008824 | 0 | 68 | Neo-adjuvant (N) | null | 2015-12-12 | OEPA | 2 | N | 270014508 | OEPA |
| 270019837 | 270008847 | 1.77 | 98.999 | Palliative (P) | 2015-12-18 | 2015-12-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014553 | CETUXIMAB + IRINOTECAN + MDG |
| 270019838 | 270008850 | 1.69 | 84.8 | Disease modification (D) | null | 2017-03-01 | BEAM | 01 | N | 270014558 | BEAM |
| 270019839 | 270008858 | 1.87 | 80.74 | Curative (C) | 2018-06-12 | 2018-06-19 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270014564 | CISPLATIN + RT |
| 270019840 | 270008877 | 1.7 | 52.3 | Curative (C) | 2018-09-03 | 2018-09-06 | ESHAP | N | N | 270014596 | ESHAP |
| 270019841 | 270014183 | 1.8 | null | Curative (C) | 2015-05-21 | 2015-06-04 | HD EuroNet-PHL-C1 OEPA | 02 | null | 270014625 | OEPA |
| 270019842 | 270008899 | 1.41 | 50.5 | Palliative (P) | null | 2019-02-07 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | 270014627 | CETUXIMAB + IRINOTECAN + MDG |
| 270019843 | 270014199 | 1.8 | 62.7 | Curative (C) | 2016-10-03 | 2016-11-15 | CISPLATIN + RT | N | N | 270014681 | CISPLATIN + RT |
| 270019845 | 270019912 | 1.8 | null | Curative (C) | 2017-03-09 | 2017-03-10 | LEAM | null | Y | 270014763 | LEAM |
| 270019846 | 270008981 | 1.76 | 71.4 | null | 2016-06-08 | 2016-06-09 | Rituximab | 02 | N | 270014792 | RITUXIMAB |
| 270019847 | 270008997 | 1.79 | 76.5 | Curative (C) | 2018-03-15 | 2018-03-16 | Mini BEAM | 99 | N | 270014831 | BEAM |
| 270019848 | 270019151 | 1.65 | 83.6 | Palliative (P) | 2016-07-18 | 2016-07-21 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 270014855 | CETUXIMAB + IRINOTECAN + MDG |
| 270019849 | 270009027 | 1.8 | 78 | Curative (C) | 2017-03-26 | 2017-04-02 | OEPA | N | N | 270014886 | OEPA |
| 270019850 | 270009052 | 1.79 | 108 | Adjuvant (A) | 2016-06-27 | 2016-06-28 | OEPA | N | Y | 270014941 | OEPA |
| 270019851 | 270009063 | 1.03 | 56.2 | Neo-adjuvant (N) | 2019-06-17 | 2019-06-19 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014959 | CETUXIMAB + IRINOTECAN + MDG |
| 270019852 | 270009068 | 1.6 | 67.8 | Disease modification (D) | 2017-12-10 | 2018-09-13 | Mini BEAM | N | N | 270014962 | BEAM |
| 270019853 | 270009088 | 1.7 | 80.74 | Not known (9) | null | 2018-04-07 | Rituximab | 02 | Y | 270014996 | RITUXIMAB |
| 270019854 | 270009093 | null | 103.4 | Curative (C) | 2018-06-02 | 2018-06-28 | BEAM | N | N | 270014999 | BEAM |
| 270019855 | 270014260 | 1.65 | 116.3 | Curative (C) | 2017-01-15 | 2017-02-06 | Cisplatin 100 + RT(H&N) 1 day | null | N | 270015011 | CISPLATIN + RT |
| 270019856 | 270019157 | null | 63 | Curative (C) | 2014-12-02 | 2014-12-10 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015043 | CISPLATIN + RT |
| 270019857 | 270009115 | 1.72 | 84.4 | Curative (C) | 2018-02-11 | 2018-02-11 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270015048 | OEPA |
| 270019858 | 270019159 | 1.66 | 53 | null | 2014-12-12 | 2014-12-18 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015083 | CETUXIMAB + IRINOTECAN + MDG |
| 270019859 | 270020251 | 0.98 | 85.7 | Curative (C) | 2016-10-05 | 2016-10-05 | ESHAP | 2 | N | 270015099 | ESHAP |
| 270019860 | 270009139 | 1.77 | 58.9 | Curative (C) | 2017-02-23 | 2017-03-02 | BEAM | N | null | 270015108 | BEAM |
| 270019861 | 270009163 | 1.74 | null | Curative (C) | 2018-02-24 | 2018-11-10 | BEAM | 2 | N | 270015192 | BEAM |
| 270019862 | 270009193 | 1.72 | 79.8 | Curative (C) | 2016-02-11 | 2016-02-11 | HD EuroNet-PHL-C1 OEPA | N | N | 270015246 | OEPA |
| 270019863 | 270009215 | 1.24 | 62.1 | Curative (C) | 2016-07-13 | 2016-07-16 | ESHAP | N | N | 270015286 | ESHAP |
| 270019864 | 270009230 | null | 63.1 | Palliative (P) | 2017-06-10 | 2017-07-28 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015310 | CETUXIMAB + IRINOTECAN + MDG |
| 270019865 | 270009231 | 1.74 | null | Curative (C) | 2016-12-05 | 2018-07-26 | LEAM | N | N | 270015319 | LEAM |
| 270019866 | 270019184 | 1.83 | null | Palliative (P) | 2017-04-15 | 2017-06-30 | Trifluridine + Tipiracil | 02 | N | 270015404 | TRIFLURIDINE + TIPIRACIL |
| 270019867 | 270009280 | 1.92 | 98.1 | Curative (C) | 2016-08-20 | 2016-09-01 | CHLVPP | N | N | 270015462 | CHLVPP |
| 270019868 | 270009283 | null | 62 | Palliative (P) | 2018-04-09 | 2019-06-26 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015465 | FLUOROURACIL |
| 270019869 | 270014343 | 1.5 | 64 | Palliative (P) | 2017-12-15 | 2018-10-30 | Shamash LBCMVD-56 | N | N | 270015489 | NOT MATCHED |
| 270019870 | 270016885 | 1.55 | 108 | Curative (C) | 2016-07-04 | 2016-09-28 | Capecitabine 42days + RT | N | N | 270015522 | CAPECITABINE + RT |
| 270019871 | 270009318 | 1.76 | 49.3 | null | 2018-09-13 | 2018-10-08 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015528 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270019872 | 270014362 | null | null | Disease modification (D) | 2018-05-29 | 2018-05-30 | Trifluridine + Tipiracil | N | N | 270015562 | TRIFLURIDINE + TIPIRACIL |
| 270019873 | 270014364 | 1.6 | 74 | Disease modification (D) | 2015-08-27 | 2015-09-19 | DHAP | 02 | N | 270015578 | DHAP |
| 270019874 | 270009404 | 1.6 | 70 | Adjuvant (A) | 2016-04-19 | 2016-04-22 | Fluorouracil + Folinic Acid Weekly | 02 | N | 270015795 | FLUOROURACIL |